To explore this possibility, we surveyed data obtained from The Cancer Genome Atlas (TCGA) to examine IL23R expression across various cancer types and found that IL23R expression was increased specifically in colon and rectal cancers when compared to other cancer types (Figure 4A). This evidence concerns the gene IL23R and rectal cancer.